Company of the week: Glaxo Wellcome
Sunday 01 August 1999
The shares fell 11 per cent, although some of the losses were recovered by Friday. Glaxo blamed competition to its migraine pill Imitrex from Merck and AstraZeneca and lagging sales of its smoking-cessation drug Zyban for the expected shortfall. The warning came as the company posted a 9.6 per cent increase in first-half earnings.
Glaxo said new drugs like Relenza for flu and Zeffix for hepatitis B will lift second-half sales and fuel "strong growth" from 2000. The company is under investor pressure to match US rivals' double-digit profit growth rates to prop up its stock price. Analysts said its forecast might be premature.
"I am quite surprised that they decided to throw in the sponge on double- digit growth this early," said Paul Diggle, an analyst with SG Securities. With new drugs reaching the market, "There is every chance they could still come in with the numbers. And the long-term growth rate doesn't change."
The decline in Glaxo's shares took them to their lowest level for more than nine months. They are down 32 per cent from their peak this year in January.
Glaxo has repeatedly committed itself to delivering double-digit sales and earnings growth this year for the past two years, a target it reiterated most recently in May. Richard Sykes, Glaxo's chairman, said he would no longer forecast future percentage growth after the latest setback.
"I have no regrets about making that statement," Mr Sykes said. "We believed we could achieve that." However, he said that because of the uncertainties about new product growth, "I don't think we are wise to continue that."
- 1 Exclusive: Abusers using spyware apps to monitor partners reaches 'epidemic proportions'
- 2 Margaret Thatcher 'expressed fears of Asian rising' at Anglo-Irish summit in 1984
- 3 Sussex couple die in suspected Christmas Day 'suicide pact'
- 4 The 'Black Museum': After 150 years, public set to see exhibits from police’s grisly crime museum
- 5 The Unluckiest People of the Year 2014 (and one very unlucky giraffe)
Exclusive: Abusers using spyware apps to monitor partners reaches 'epidemic proportions'
UK weather: Warning for more snow and ice as freezing temperatures and gales hit Britain
UK weather: Travel chaos continues as King's Cross train delays add to snow on roads
The Unluckiest People of the Year 2014 (and one very unlucky giraffe)
North Korea calls Barack Obama 'a monkey' in latest attack as 'The Interview' row festers
British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
Germany anti-Islam protests: 17,000 march on Dresden against 'Islamification of the West'
Ukip member gets into Christmas spirit with Union Flag plea to Santa 'for our country back'
Immigrants make UK racist, says Ukip councillor Trevor Shonk
BBC director Danny Cohen: Rising UK antisemitism makes me feel more uncomfortable than ever
Katie Hopkins speaks out on childhood obesity: 'Parents of fat children should be prosecuted for child cruelty'
iJobs Money & Business
Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...
Not specified: Selby Jennings: Quantitative Research | Global Equity | New Yor...
Not specified: Selby Jennings: SVP Model Validation This top tiered investment...
Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...